Evidence map›Paper›PMID 34449109›Full record

ArticleAdvanced materials (Deerfield Beach, Fla.)2021

An Injectable Meta-Biomaterial: From Design and Simulation to In Vivo Shaping and Tissue Induction.

Amélie Béduer, Fabien Bonini, Connor A Verheyen, Martina Genta, Mariana Martins, Joé Brefie-Guth, Josefine Tratwal, Aleksandra Filippova, Patrick Burch, Olaia Naveiras and 1 more

Abstract read
In one paragraph

Article in Advanced materials (Deerfield Beach, Fla.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Dynamic Covalent Hydrogels: Strong yet Dynamic.Gels (Basel, Switzerland) · 2022
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Amélie BéduerDepartment of Pathology and Immunology, Faculty of Medicine, University of Geneva, Rue Michel-Servet 1, Geneva, CH-1211, Switzerland.
Fabien BoniniDepartment of Pathology and Immunology, Faculty of Medicine, University of Geneva, Rue Michel-Servet 1, Geneva, CH-1211, Switzerland.ORCID https://orcid.org/0000-0002-0632-3893
Connor A VerheyenSchool of Engineering, École Polytechnique Fédérale de Lausanne (EPFL), LMIS4. BM, Station 17, Lausanne, CH-1015, Switzerland.
Martina GentaSchool of Engineering, École Polytechnique Fédérale de Lausanne (EPFL), LMIS4. BM, Station 17, Lausanne, CH-1015, Switzerland.
Mariana MartinsVolumina-Medical SA, Route de la Corniche 5, Epalinges, CH-1066, Switzerland.ORCID https://orcid.org/0000-0003-3873-2840
Joé Brefie-GuthDepartment of Pathology and Immunology, Faculty of Medicine, University of Geneva, Rue Michel-Servet 1, Geneva, CH-1211, Switzerland.
Josefine TratwalDepartment of Biomedical Sciences, Laboratory of Regenerative Hematopoiesis, University of Lausanne, Rue du Bugnon 27, Lausanne, CH-1011, Switzerland.ORCID https://orcid.org/0000-0003-2136-0462
Aleksandra FilippovaDepartment of Pathology and Immunology, Faculty of Medicine, University of Geneva, Rue Michel-Servet 1, Geneva, CH-1211, Switzerland.
Patrick BurchSchool of Engineering, École Polytechnique Fédérale de Lausanne (EPFL), LMIS4. BM, Station 17, Lausanne, CH-1015, Switzerland.
Olaia NaveirasDepartment of Biomedical Sciences, Laboratory of Regenerative Hematopoiesis, University of Lausanne, Rue du Bugnon 27, Lausanne, CH-1011, Switzerland.ORCID https://orcid.org/0000-0003-3434-0022
Thomas BraschlerDepartment of Pathology and Immunology, Faculty of Medicine, University of Geneva, Rue Michel-Servet 1, Geneva, CH-1211, Switzerland.ORCID https://orcid.org/0000-0003-1811-1713

Funding

Anna Fuller FundGebert-Rüf foundation GRS-0043/15Swiss National Science Foundation PP00P2_163684Swiss National Science Foundation PP00P2_194813Swiss National Science Foundation PP00P3_183725Swiss National Science Foundation PZ00P2_161347University of GenevaUniversity of LausanneWhitaker International Fellowship
6 · The paper itself

Abstract

A novel type of injectable biomaterial with an elastic softening transition is described. The material enables in vivo shaping, followed by induction of 3D stable vascularized tissue. The synthesis of the injectable meta-biomaterial is instructed by extensive numerical simulation as a suspension of irregularly fragmented, highly porous sponge-like microgels. The irregular particle shape dramatically enhances yield strain for in vivo stability against deformation. Porosity of the particles, along with friction between internal surfaces, provides the elastic softening transition. This emergent metamaterial property enables the material to reversibly change stiffness during deformation, allowing native tissue properties to be matched over a wide range of deformation amplitudes. After subcutaneous injection in mice, predetermined shapes can be sculpted manually. The 3D shape is maintained during excellent host tissue integration, with induction of vascular connective tissue that persists to the end of one-year follow-up. The geometrical design is compatible with many hydrogel materials, including cell-adhesion motives for cell transplantation. The injectable meta-biomaterial therefore provides new perspectives in soft tissue engineering and regenerative medicine.

Indexed as

Tissue EngineeringAnimalsBiocompatible MaterialsCell AdhesionElastic ModulusFemaleHydrogelsMaterials TestingMicePorosityRegenerative MedicineBiocompatible MaterialsHydrogelselastic softeninginjectable metamaterialsshapingtissue reconstructionvascularization

Identifiers

PMID34449109
PMCPMC11469256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.